Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immunic Inc (NQ: IMUX )

1.250 +0.010 (+0.80%)
Streaming Delayed Price Updated: 12:04 PM EDT, May 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Immunic Inc

< Previous 1 2 3 4 5 Next >
Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones
Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones 
Via News Direct
Topics Intellectual Property
Exposures Intellectual Property
IMUX Stock Earnings: Immunic Misses EPS for Q1 2024
IMUX stock results show that Immunic missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal
Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal 
Via News Direct
Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month
--News Direct-- 
Via News Direct
Immunic And 2 Other Stocks Under $2 Insiders Are Buying
The Dow Jones index closed lower by over 20 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
Exposures US Equities
Immunic's Earnings Outlook
Via Benzinga
Immunic: Q3 Earnings Insights
Via Benzinga
A Preview Of Immunic's Earnings
Via Benzinga
Immunic "super excited" about latest PMS trial data
--News Direct-- 
Via News Direct
What's Going On With Immunic Stock?
Immunic, Inc. (NASDAQ: IMUX) shares are roughly flat following strength early Friday after the company announced a three-tranche private placement of up to $240 million. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Pre-market stock movers are worth checking on Friday as we lay out all of the biggest stories worth keeping tabs on this morning! 
Via InvestorPlace
Immunic CSO hails "great" progress with MS program
--News Direct-- 
Via News Direct
Immunic Inc eyeing "big step" for multiple sclerosis patients
--News Direct-- 
Via News Direct
Immunic Inc set to bring relief with encouraging results
Immunic Inc set to bring relief with encouraging results 
Via News Direct
Recap: Immunic Q1 Earnings
Via Benzinga
Why Startek Shares Are Trading Higher By 29%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers SuperCom Ltd. (NASDAQ: SPCB) shares jumped 89% to $0.6805, after falling 13% on Monday. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Multiple Sclerosis Impacts 1M People In US - Immunic Reveals 'Positive' Data From Nerve Disorder Candidate
Immunic Inc (NASDAQ: IMUX) announced interim data from its phase 2 CALLIPER trial of nuclear receptor-related 1 (Nurr1) activator, vidofludimus calcium (IMU-838), in patients with  
Via Benzinga
Why Immunic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Gainers SuperCom Ltd. (NASDAQ: SPCB) shares rose 78.4% to $0.6425 in pre-market trading, after falling 13% on Monday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to dive into the biggest pre-market stock movers with all the most recent news moving shares on Tuesday morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Immunic CEO hails "great day" after completing IMU-838 phase 2 trial enrolment
--News Direct-- 
Via News Direct
Immunic CEO says Q2 results "couldn't be better"
--News Direct-- 
Via News Direct
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Immunic IMU-856 trial data "clearly goes beyond" initial expectations
Immunic IMU-856 trial data "clearly goes beyond" initial expectations 
Via News Direct
Immunic gets a "positive surprise" from lead asset trial
Immunic gets a "positive surprise" from lead asset trial 
Via News Direct
Why Kura Sushi Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 104% to $5.55 after the company announced it has been selected by the U.S. Department of Defense for a position on the multiple award Indefinite... 
Via Benzinga
After Positive Data In Ulcerative Colitis Study, Immunic Prioritizes Vidofludimus Calcium Program With One More Candidate
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.